Clinical Trials for Recurrent Hepatocellular Carcinoma

Find clinical trials for recurrent hepatocellular carcinoma. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

NCT ID: NCT06968195

This clinical trial is investigating a new treatment called RPCAR01 for patients with advanced liver cancer known as hepatocellular carcinoma (HCC). Specifically, the trial focuses on patients whos...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Buffalo, New York, United States

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

NCT ID: NCT03186898

This clinical trial is investigating the effectiveness of two types of radiation therapy—proton therapy and photon therapy—for treating patients with liver cancer that cannot be surgically removed ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Cleveland, Ohio, United States, Saint Louis, Missouri, United States +28 more

Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC

NCT ID: NCT04615143

This clinical trial is looking at the use of two treatments, Tislelizumab alone or combined with Lenvatinib, for patients who have recurrent hepatocellular carcinoma (a type of liver cancer) and ca...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

NCT ID: NCT05103904

This clinical trial is studying a medication called lenvatinib to see if it can help patients with liver cancer (hepatocellular carcinoma) that has returned after they have received a liver transpl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Birmingham, Alabama, United States, Scottsdale, Arizona, United States +2 more

The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma

NCT ID: NCT06609850

This clinical trial is studying a new treatment approach for patients with recurrent hepatocellular carcinoma (HCC), which is a type of liver cancer that has come back after initial treatment. The ...

Recruiting

Phase: NA Type: interventional Locations: Beijing, None Selected, China

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT ID: NCT04851119

This clinical trial is studying a new medication called tegavivint, which is being tested to see if it can help patients with certain types of solid tumors that have either come back after treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Saint Louis, Missouri, United States +20 more

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

NCT ID: NCT04800497

This clinical trial is exploring the role of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma (HCC), a type of liver cancer. The researchers want to understand how these cel...

Recruiting

Type: observational Locations: Rozzano, , Italy, Milano, , Italy +2 more

Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC

NCT ID: NCT04663035

This clinical trial is comparing two treatment options for patients with early recurrent hepatocellular carcinoma (HCC), which is a type of liver cancer. The study is examining whether adding a med...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions